expansion and spectrum acquisition. FY18 Guidance On 23 January 2018, the company has acquired 80.10% of CSL shares through tender offering, with an aim to strengthen the growth potential in enterprise
from January 1 - December 31, 2018, to the shareholders holding total 120 million shares, at the rate of Baht 1.80 per share, for total payment amount Baht 216 million. Said dividend payments are to be
. 2. Approved the establishment of a new Subsidiary with a registered capital of Baht 0.50 million. DOD holds 51% of shares to engage in the food supplement distribution business, which is a joint
balance is expected to be used for the subscription of shares in the announced rights offering of MACO and expansion of the digital and online-related businesses. 1 In 1Q 2018/19, VGI recorded receivables
UE, which ws funded by a capital increase via issuance of preferred shares last quarter. The majority of assets acquired by EBT of UE was the BTS- Sansiri JV (Sansiri JV) Net debt to equity ratio as
Indorama Ventures Public Company Limited for second quarter ended June 30, 2019 We are pleased to submit: 1. Consolidated and Company only Quarterly Review of Financial Statements for for the second quarter
position for the first quarter of 2018 with those of 2017. This report discusses principal changes in the unreviewed consolidated financial statements. Overall market environment The Thai economy for the
first quarter of 2018 with those of 2017. This report discusses principal changes in the reviewed consolidated financial statements. Overall market environment The Thai economy for the first quarter of
Public Company Limited and its subsidiaries would like to notify the operating results stated in consolidated financial statements for the year 2019. The details as follows: The Structure of Revenues R&B
, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th Consolidated For the Year Ended December 31 2019 2018 MB % MB % Total revenues 375.89 100.00 317.58 100.00